错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Peripheral zone thickness in preoperative MRI is predictive of Trifecta achievement after Holmium laser enucleation of the prostate (HoLEP).

  • Jae Hyon Park,
  • Jongjin Yoon,
  • Insun Park,
  • Jun Gu Kang,
  • Jongsoo Lee,
  • Jang Hwan Kim,
  • Dae Chul Jung,
  • Byung-Chul Kang,
  • Young Taik Oh

摘要

Purpose

To investigate various anatomical features of the prostate using preoperative MRI and patients’ clinical factors to identify predictors of successful Holmium:YAG laser enucleation of the prostate (HoLEP).

Methods

71 patients who had received HoLEP and undergone a 3.0-T prostate MRI scan within 6 months before surgery were retrospectively enrolled. MRI features (e.g., total prostate and transitional zone volume, peripheral zone thickness [PZT], BPH patterns, prostatic urethral angle, intravesical prostatic protrusion, etc.) and clinical data (e.g., age, body mass index, surgical technique, etc.) were analyzed using univariable and multivariable logistic regression to identify predictors of successful HoLEP. Successful HoLEP was defined as achieving the Trifecta, characterized by the contemporary absence of postoperative complications within 3 months, a 3-month postoperative maximum flow rate (Qmax) > 15 mL/s, and no urinary incontinence at 3 months postoperatively.

Results

Trifecta achievement at 3 months post-surgery was observed in 37 (52%) patients. Patients with Trifecta achievement exhibited a lower preoperative IPSS-quality of life score (QoL) (4.1 vs. 4.5, P = 0.016) and a thinner preoperative peripheral zone thickness (PZT) on MRI (7.9 vs.10.3 mm, P < 0.001). In the multivariable regression analysis, a preoperative IPSS-QoL score < 5 (OR 3.98; 95% CI, 1.21–13.07; P = 0.017) and PZT < 9 mm (OR 11.51; 95% CI, 3.51–37.74; P < 0.001) were significant predictors of Trifecta achievement after HoLEP.

Conclusions

Alongside the preoperative QoL score, PZT measurement in prostate MRI can serve as an objective predictor of successful HoLEP. Our results underscore an additional utility of prostate MRI beyond its role in excluding concurrent prostate cancer.